The Clorox Company
CLXConsumer DefensiveNASDAQHousehold & Personal Products
Scan Results
Daily timeframeThe Clorox Company manufactures and markets consumer and professional products worldwide. With a market capitalization of $10.84B, it sits in large-cap territory. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International.
Market Cap
$10.84B
Beta
0.57
P/E (TTM)
14.57
P/E (Fwd)
14.24
EPS (TTM)
$6.15
EPS (Fwd)
$6.29
ROE
546.1%
ROA
11.0%
Cash
$1.19B
Total Debt
$4.49B
Free CF
$62.8M
52W Change
-30.9%
Annual Financials
Cash vs Debt
The company holds $1.19B in cash, though total debt stands at $4.49B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $62.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 546.1%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 11.0% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $7.11B (2022) to $7.10B (2025).
CLX's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. No single metric tells the full story. Reviewing CLX's risk profile alongside its fundamentals and technical indicators provides a more complete picture.